Anbenitamab Active Not Recruiting Phase 2 Trials for Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04165993Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer